Stock Scorecard



Stock Summary for Novartis AG (NVS) - $124.21 as of 8/18/2025 11:07:29 AM EST

Total Score

11 out of 30

Safety Score

68 out of 100

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for NVS

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for NVS

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for NVS

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for NVS

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for NVS (68 out of 100)

Stock Price Rating (Max of 10) 10
Historical Stock Price Rating (Max of 10) 9
Stock Price Trend (Max of 10) 9
Book Value (Max of 10) 7
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 0
Analyst Strong Buy Ratings (Max of 5) 4
Dividend Yield Percentage (Max of 10) 6
Operating Margin (Max of 10) 6
Trading Volume (Max of 10) 9
Price to Earnings (Max of 10) 8
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Latest News for for NVS

Is Vanguard International Dividend Appreciation ETF ( VIGI ) a Strong ETF Right Now? 8/14/2025 10:20:00 AM
Alvotech Reports Results for the First Six Months of 2025 and Provides a Business Update 8/13/2025 8:15:00 PM
Alvotech Reports Results for the First Six Months of 2025 and Provides a Business Update 8/13/2025 8:15:00 PM
Vor Bio Rallies On Strong Data For Autoimmune Drug Candidate - Vor Biopharma ( NASDAQ:VOR ) 8/13/2025 3:15:00 PM
Novartis Sees Hope In Reducing Lifelong Treatment Burden For Autoimmune Blood Disorder - Novartis ( NYSE:NVS ) 8/12/2025 1:43:00 PM
Why Is Novartis Stock Gaining Monday? - Novartis ( NYSE:NVS ) 8/11/2025 1:53:00 PM
Genmab/AbbVie Partnered Blood Cancer Combination Drug Cuts Risk Of Disease Progression By 79% - Genmab ( NASDAQ:GMAB ) 8/8/2025 5:23:00 PM
Genmab Announces Financial Results for the First Half of 2025 8/7/2025 3:08:00 PM
Is SPDR MSCI EAFE StrategicFactors ETF ( QEFA ) a Strong ETF Right Now? 7/30/2025 10:20:00 AM
Is FlexShares International Quality Dividend ETF ( IQDF ) a Strong ETF Right Now? 7/25/2025 10:20:00 AM

Financial Details for NVS

Company Overview

Ticker NVS
Company Name Novartis AG
Country USA
Description Novartis AG researches, develops, manufactures and markets medical devices worldwide. The company is headquartered in Basel, Switzerland.
Sector Name LIFE SCIENCES
Industry Name PHARMACEUTICAL PREPARATIONS
Most Recent Quarter 6/30/2025
Next Earnings Date 10/28/2025

Stock Price History

Last Day Price 124.21
Price 4 Years Ago 74.81
Last Day Price Updated 8/18/2025 11:07:29 AM EST
Last Day Volume 1,179,429
Average Daily Volume 1,904,308
52-Week High 124.83
52-Week Low 92.72
Last Price to 52 Week Low 33.96%

Valuation Measures

Trailing PE 17.80
Industry PE 43.35
Sector PE 59.06
5-Year Average PE 15.33
Free Cash Flow Ratio 36.11
Industry Free Cash Flow Ratio 15.81
Sector Free Cash Flow Ratio 30.26
Current Ratio Most Recent Quarter 0.82
Total Cash Per Share 3.44
Book Value Per Share Most Recent Quarter 21.69
Price to Book Ratio 5.63
Industry Price to Book Ratio 31.11
Sector Price to Book Ratio 26.93
Price to Sales Ratio Twelve Trailing Months 4.30
Industry Price to Sales Ratio Twelve Trailing Months 34.46
Sector Price to Sales Ratio Twelve Trailing Months 15.21
Analyst Buy Ratings 0
Analyst Strong Buy Ratings 2

Share Statistics

Total Shares Outstanding 1,935,850,000
Market Capitalization 240,451,928,500
Institutional Ownership 7.19%

Dividends

Ex-Dividend Date 3/12/2025
Previous Dividend Amount 3.7395
Current Dividend Amount 3.9940
Total Years Dividend Increasing 5
Trailing Annual Dividend Rate 3.99
Trailing Annual Dividend Yield 3.27%
Forward Annual Dividend Rate 3.99
Forward Annual Dividend Yield 3.27%
5-Year Dividend Payments Count 5
3-Year Average Dividend Yield 3.86%
5-Year Average Dividend Yield 4.03%
1-Year Dividend Growth Rate Percentage 6.80%
3-Year Dividend Growth Rate Percentage 6.84%
5-Year Dividend Growth Rate Percentage 5.71%
All-Time Dividend Growth Rate Percentage 7.66%
Dividend Payout Ratio 58.22%

Income Statement

Quarterly Earnings Growth YOY 29.60%
Annual Earnings Growth -19.59%
Reported EPS 12 Trailing Months 6.86
Reported EPS Past Year 4.70
Reported EPS Prior Year 7.81
Net Income Twelve Trailing Months 9,617,024,000
Net Income Past Year 11,941,000,000
Net Income Prior Year 14,850,000,000
Quarterly Revenue Growth YOY 15.30%
5-Year Revenue Growth 1.22%
Operating Margin Twelve Trailing Months 36.80%

Balance Sheet

Total Cash Most Recent Quarter 6,656,000,000
Total Cash Past Year 11,459,000,000
Total Cash Prior Year 13,393,000,000
Net Cash Position Most Recent Quarter -15,814,000,000
Net Cash Position Past Year -9,907,000,000
Long Term Debt Past Year 21,366,000,000
Long Term Debt Prior Year 18,436,000,000
Total Debt Most Recent Quarter 22,470,000,000
Equity to Debt Ratio Past Year 0.67
Equity to Debt Ratio Most Recent Quarter 0.65
Total Stockholder Equity Past Year 44,046,000,000
Total Stockholder Equity Prior Year 46,667,000,000
Total Stockholder Equity Most Recent Quarter 41,985,000,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months 16,806,000,000
Free Cash Flow Per Share Twelve Trailing Months 8.68
Free Cash Flow Past Year 13,805,000,000
Free Cash Flow Prior Year 11,705,000,000

Options

Put/Call Ratio 1.68
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD 0.21
MACD Signal -0.34
20-Day Bollinger Lower Band 105.61
20-Day Bollinger Middle Band 114.99
20-Day Bollinger Upper Band 124.37
Beta 0.55
RSI 59.17
50-Day SMA 108.38
150-Day SMA 96.63
200-Day SMA 91.14

System

Modified 8/16/2025 6:20:06 AM EST